
|Articles|July 30, 2021
Pharmacy Clinical Pearl of the Day: Lipophilic Statins vs Hydrophilic Statins
Author(s)Saro Arakelians, PharmD
Lipophilic statins for dyslipidemia penetrate muscle more easily than hydrophilic statins and are associated with a higher incidence of adverse effects.
Advertisement
List of statins for dyslipidemia and lipophilic versus hydrophilic treatments:
- Fluvastatin (Lescol)
- Lovastatin (Mevacor, Altoprev)
- Pravastatin (Pravachol)
- Simvastatin (Zocor)
- Atorvastatin (Lipitor)
- Rosuvastatin (Crestor)
- Pitavastatin (Livalo)
Explanation:
- Myalgia may be related to lipophilicity (fat loving) and to high dosage, as well as interaction with other medications.
- Lipophilic statins penetrate muscle more easily than hydrophilic statins and are associated with a higher incidence of adverse effects, particularly myopathy, although reports of muscle toxicity, including rhabdomyolysis, have been reported with all statins.
- Hydrophilic statins stay out of muscle and brain tissue, which are fat filled.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5

















































































































































































































